Role of calpain in spinal cord injury: Effects of calpain and free radical inhibitors

Annals of the New York Academy of Sciences

Volumn 844, Issue , 1998, Pages 131-137

  Banik, N L ^a   Shields, D C ^a   Ray, S ^a   Davis, B ^a   Matzelle, D ^a   Wilford, G ^a   Hogan, E L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; CALPEPTIN; CYTOSKELETON PROTEIN; DNA FRAGMENT; FREE RADICAL; MESSENGER RNA; METHYLPREDNISOLONE; MYELIN PROTEIN; NEUROFILAMENT PROTEIN;

APOPTOSIS; CELL DEATH; CELL MEMBRANE; CELL ULTRASTRUCTURE; CHEMOLUMINESCENCE; CONFERENCE PAPER; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MEMBRANE STRUCTURE; MOTOR PERFORMANCE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; SPINAL CORD INJURY;

ANIMALIA;

EID: 0031849873     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb08228.x     Document Type: Conference Paper

References (41)

1. SIMAN, R. et al. 1985. Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res. 347: 399-403.
2. HAMAKUBO, R. et al. 1986. Distribution of calpains I and II in rat brain. J. Neurosci. 6: 3103-3111.
3. CHAKRABARTI, A.K. et al. 1989. The regional and subcellular distribution of calcium-activated neutral proteinase (CANP) in the bovine central nervous system. J. Neurosci. Res. 14: 259-266.
4. NIXON, R.A. 1989. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis. Ann. N. Y. Acad. Sci. 568: 198-208.
5. KAMAKURA, K. et al. 1992. Distribution of calcium-activated neutral proteinase inhibitor in the central nervous system of the rat. J. Neurosci. 31: 543-548.
6. ONIZUKA K. et al. 1995. Distribution of mu-calpain proenzyme in the brain and other neural tissues in the rat. Brain Res. 697: 179-186.
7. LI, Z. & N.L. BANIK. 1995. The localization of mcalpain in myelin: Immunocytochemical evidence in different areas of rat brain and nerves. Brain Res. 695: 112-121.
8. SCHLAEPFER, W.W. & U.J.P. ZIMMERMAN. 1990. The degradation of neurofilaments by calpains. In Intracellular Calcium-Dependent Proteolysis. R.L. Mellgren & T. Murachi, Eds.: 241-250. CRC Press. Boca Raton, FL.
9. CROALL, D.E. & G.N. DEMARTINO. 1991. Calcium-activated neutral proteinase (calpain) system: Structure, function, and regulation. Physiol. Rev. 71: 813-847.
10. POSMANTUR, R. et al. 1994. Neurofilament 68 and neurofilament 200 protein levels after traumatic brain injury. J. Neurotrauma 11: 533-545.
11. SAATMAN, K.E. et al. 1996. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55: 850-860.
12. BANIK, N.L. et al. 1997. Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res. 752: 301-306.
13. SPRINGER, J.E. et al. 1997. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: Attenuation with Raluzole pretreatment. J. Neurochem. 69: 1592-1600.
14. BARTUS, R.T. 1997. The calpain hypothesis of neurodegeneration: Evidence for a common cytotoxic pathway. Neuroscientist 3: 314-327.
15. BANIK, N.L. et al. 1980. The effect of spinal cord trauma on myelin. J. Neuropathol. Exp. Neurol. 39: 232-244.
16. BALENTINE, J.D. 1978. Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab. Invest. 39: 254-266.
17. BRESNAHAN, J.C. 1978. An electron microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the Rhesus monkey. J. Neurol. Sci. 37: 59-82.
18. 2+-accumulation in experimental spinal cord trauma. Brain Res. 211: 476-179.
19. STOKES, B.T. et al. 1983. Extracellular calcium activity in the injured spinal cord. Exp. Neurol. 80: 561-572.
20. YOUNG, W. et al. 1982. Extracellular calcium ionic activity in experimental spinal cord contusion. Brain Res. 53: 105-113.
21. BANIK, N.L. et al. 1986. Proteolytic enzymes in spinal cord injury. J. Neurol. Sci. 73: 245-256.
22. BANIK, N.L. et al. 1982. Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem. Res. 7: 1465-1475.
23. JANE, J. et al. 1985. Minor and moderate head injury model system. In Trauma of Central Nervous System. R.G. Dacey, Jr., H.R. Winn, R.W. Rimel & J.A. Jane, Eds.: 2-33. Raven Press. New York.
24. FISCHER, I. et al. 1991. Calpain-mediated proteolysis of microtubule-associated proteins MAP1 and MAP2 in developing brain. Neurochem. Res. 16: 891-898.
25. HOGAN, E.L. & N.L. BANIK. 1985. Biochemistry of the spinal cord. In Handbook of Neurochemistry. Vol. 10. A. Lajtha, Ed.: 285-337. Plenum Press, New York.
26. LI, Z. et al. 1996. Role of calpain in spinal cord injury: Increased calpain immunoreactivity in rat spinal cord trauma. Neurochem Res. 21: 439-446.
27. LI, Z. et al. 1995. Role of calpain in spinal cord injury: Increased calpain immunoreactivity in compression injury in rat. Neurochem. Int. 27: 425-532.
28. RAY, S. et al. 1997. Increased calpain expression, cell death, and neuroprotection in rat spinal cord injury. In Seventh International Symposium for Neurological Regeneration. Asilomar Conference Center, Pacific Grove, CA.
29. CROWE, M.J. et al. 1996. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature Med. 3: 73-76.
30. BANIK, N.L. et al. 1996. Progressive degradation of MAG in spinal cord injury. J. Neurotrauma 222: 230.
31. SHIELDS, D.C. et al. 1997. Calpain, a mediator of myelin breakdown in demyelinating diseases. Ann. N. Y. Acad. Sci. 825: 128-130.
32. SHIELDS, D.C. et al. 1997. Increased calpain expression in experimental demyelinating optic neuritis: An immunocytochemical study. Brain Res. In press.
33. LEE, Y.L. et al. 1997. Factors induced after rat spinal cord injury. J. Neurochem. 69 (SUPPL.): S144.
34. DESHPANDE, R.V. et al. 1995. Calpain expression in lymphoid cells: Increased mRNA and protein levels after cell activation. J. Biol. Chem. 270: 2497-2505.
35. HALL, E.D. 1991. The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76: 13-22.
36. BENUCK, M. et al. 1992. Peroxidative effects on calpain activity in brain of young and adult rats. Brain Res. 596: 296-298.
37. SQUIER, K.T. et al. 1994. Calpain activation in apoptosis. J. Cell. Physiol. 59: 229-237.
38. +-induced donors by cysteine protease inhibitors. J. Immunol. 153: 862-872.
39. BANIK, N.L. et al. 1996. A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: Inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation. Brain Res. 748: 205-210.
40. BRACKEN, M.B. et al. 1992. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the Second National Acute Spinal Cord Injury Study. J. Neurosurg. 76: 23-31.
41. BRAUGHLER, J.M. & E.D. HALL. 1984. Effects of multidose methylprednisolone sodium succinate-administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61: 290-295.